-+ 0.00%
-+ 0.00%
-+ 0.00%

Jamieson Wellness (TSX:JWEL) Can Earnings Growth Justify A 24x P E?

Simply Wall St·08/08/2026 05:24:17
语音播报

Jamieson Wellness stock has been grinding higher in recent months, yet today’s Q2 print puts the focus squarely on whether that premium P/E of 24x is still justified. The headline is simple. Earnings power is doing the heavy lifting. Basic earnings per share for the quarter came in at CA$0.43 on revenue of CA$233.8m, feeding into trailing twelve month earnings of CA$1.89 per share. For a company already trading above industry valuation averages, this quarter is less about surprise and more about whether profit delivery can continue to support that richer multiple.

Love Jamieson Wellness earnings holding up but unsure if that 24x P/E is the right premium to pay right now? Check out the 11 high quality undervalued stocks for stocks that pair solid fundamentals with more modest valuation multiples.

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs Q2 2025): CA$233.8m vs. CA$199.1m (up about 17.5%)
  • Net Income, Excl. Extra Items (Q2 2026 vs Q2 2025): CA$17.9m vs. CA$13.1m (up about 37.3%)
  • Basic EPS (Q2 2026 vs Q2 2025): CA$0.43 vs. CA$0.31 (up about 38.0%)
  • Trailing 12 Month Net Income, Excl. Extra Items (Q2 2026 TTM vs Q2 2025 TTM): CA$78.6m vs. CA$58.0m (up about 35.5%)

Prefer clean visuals instead of scrolling through lines of earnings figures and P/E discussion? See Jamieson Wellness in a full visual breakdown that highlights its valuation picture at a glance in the company report for Jamieson Wellness.

TSX:JWEL Trailing 12-Month Earnings & Revenue History as at Aug 2026
TSX:JWEL Trailing 12-Month Earnings & Revenue History as at Aug 2026

Jamieson Wellness results support a steady bull story

For investors leaning positive on Jamieson Wellness, the latest quarter broadly fits the idea of a resilient consumer health platform. Revenue of CA$233.8m and basic EPS of CA$0.43 both point in the same direction as the trailing 12 month EPS of CA$1.89. That suggests earnings power is not just a one quarter event. The stock’s 90 day return of about 29% also shows recent market appreciation lining up with this improving profit picture.

Bear case focuses on resilience, not collapse

On the cautious side, the key risk in the narrative is that competition, regulation, or international expansion could pressure profitability. The current data does not show that pressure biting into earnings yet, given higher net income and EPS compared with Q2 2025. The extended credit facilities to 2031 add financial flexibility, which can be helpful but also increases responsibility to deploy capital carefully. For now the numbers suggest Jamieson Wellness is managing these risks rather than absorbing visible damage.

After extended credit facilities and dividends that are not well covered by free cash flow, Review our risk analysis for Jamieson Wellness which shows 2 important warning signs

Stay Ahead With Simply Wall St

If Jamieson Wellness has your attention after its recent earnings strength and 24x P/E, register for free with Simply Wall St and add it to your Watchlist to track the share price against fair value and spot a more compelling entry point. Once you decide to own the stock, use the Portfolio Command Center to cut through market noise and focus on the updates that really matter to your holdings. For a longer term view, tap into the collective insight of other investors through the Community and see how sentiment is evolving around Jamieson Wellness. This way you can surface potential catalysts or risks early and keep a step ahead of the market.

Seeking Alternatives Beyond Jamieson Wellness?

Fresh ideas move fast. Some stocks show early breakout signs, build quiet momentum, or get caught dropping before a reset. Scan these under the radar for now, and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.